The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells
Abstract
A predominant response to myelin oligodendrocyte glycoprotein (MOG) was recently observed in patients with multiple sclerosis (MS). To study the possible pathogenic role of T cell response to MOG in MS, we have investigated the encephalitogenic potential of MOG. Synthetic MOG peptides, pMOG 1‐21, 35–55, 67–87, 104–117 and 202–218, representing predicted T cell epitopes, were injected into C57BL/6J and C3H.SW (H‐2 b) mice. The mice developed significant specific T cell responses to pMOG 1–21, pMOG 35–55 and pMOG 104–117. However, pMOG 35–55 was the only MOG peptide which could induce neurological impairment. The highly reproducible disease was chronic, with ascending paralysis and neuropathology comparable with those observed in experimental autoimmune encephalomyelitis (EAE) induced by myelin basic protein or proteolipid protein, except that in H‐2 b mice the disease was consistently non‐remitting. These features differ markedly from those which we recently observed in PL (H‐2 u) mice with pMOG 35–55‐induced disease. In PL mice, pMOG 35–55‐induces atypical chronic relapsing EAE, the expression and progression of which are unpredictable. Hence, in different mouse strains, the same MOG peptide can induce typical EAE characterized by ascending paralysis, or atypical EAE with unpredictable clinical signs. pMOG 35–55‐specific T cells from H‐2 b mice recognized an epitope within amino acids 40–55 of the MOG molecule, and pMOG 40–55‐reactive T cell lines were encephalitogenic upon transfer into syngeneic recipients. The encephalitogenic pMOG 35–55‐reactive C57BL/6J T cell lines expressed Vβ1, Vβ6, Vβ8, Vβ14 and Vβ15 gene segments, and the pMOG 35–55‐reactive C3H.SW T cell lines expressed Vβ1, Vβ2, Vβ6, Vβ8, Vβ10, Vβ14, and Vβ15 gene segments. However, in both mouse strains, the utilization of the Vβ8 gene product was predominant (40–43 %). The highly reproducible encephalitogenic activity of pMOG 35–55 strongly suggests a pathogenic role for T cell reactivity to MOG in MS and supports the possibility that MOG may also be a primary target antigen in the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Antibodies: A laboratory manual
J.L. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90307-1 · Cited by 5,089
The T Lymphocyte In Experimental Allergic Encephalomyelitis
Zamvil, S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.579 · Cited by 1,009
ACHAORBEA, H. (1988) · Cell · doi:10.1016/0092-8674(88)90558-2 · Cited by 925
Ben‐Nun, A., Wekerle, H., & Cohen, I. R. (1981) · European Journal of Immunology · doi:10.1002/eji.1830110307 · Cited by 916
Self-citationT-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens
MacDonald, H. R., Schneider, R., Lees, R. K., Howe, R. C., Acha-Orbea, H., Festenstein, H., Zinkernagel, R. M., & Hengartner, H. (1988) · Nature · doi:10.1038/332040a0 · Cited by 888
Linington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed · Cited by 708
Staerz, U. D., Rammensee, H., Benedetto, J. D., & Bevan, M. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.3994 · Cited by 663
Urban, J. L., Kumar, V., Kono, D. H., Gomez, C., Horvath, S. J., Clayton, J., Ando, D. G., Sercarz, E. E., & Hood, L. (1988) · Cell · doi:10.1016/0092-8674(88)90079-7 · Cited by 547
T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination
Zamvil, S., Nelson, P., Trotter, J., Mitchell, D., Knobler, R., Fritz, R., & Steinman, L. (1985) · Nature · doi:10.1038/317355a0 · Cited by 530
Cited by
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
“MOG-induced EAE is best examined in C57/BL6 mice, in which the MOG(35−55) peptide induces a chronic, nonrelapsing EAE (137).”
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017
“…Cabarrocas et al. (2003), Sun et al. (2001) T-cell-and macrophage-mediated demyelination Chronic EAE in C57BL/6 mice induced by MOG peptide 35-55 Mendel et al. (1995) T-cell-and antibody-mediated demyelination Chronic EAE in DA and BN rats or in marmosets sensitized with recombinant MOG 1-125…”
BackgroundSack, D. A., Sack, R. B., Nair, G. B., & Siddique, A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15328-7 · Cited by 905
Bettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., & Kuchroo, V. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021603 · Cited by 825
Kohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4712 · Cited by 782
Hellenbrand, D. J., Quinn, C. M., Piper, Z. J., Morehouse, C. N., Fixel, J. A., & Hanna, A. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02337-2 · Cited by 635
Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells
Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A., & Goverman, J. M. (2008) · Nature Medicine · doi:10.1038/nm1715 · Cited by 630
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Hemmer, B., Kerschensteiner, M., & Korn, T. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70305-9 · Cited by 584
Active induction of experimental allergic encephalomyelitis
Stromnes, I. M., & Goverman, J. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.285 · Cited by 573
Bettelli, E., Prabhu Das, M., Howard, E. D., Weiner, H. L., Sobel, R. A., & Kuchroo, V. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3299 · Cited by 556
McGeachy, M. J., Stephens, L. A., & Anderton, S. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3025 · Cited by 556
Multiple sclerosis: experimental models and reality
Lassmann, H., & Bradl, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1631-4 · Cited by 525
Liliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 524
Webster, K. E., Walters, S., Kohler, R. E., Mrkvan, T., Boyman, O., Surh, C. D., Grey, S. T., & Sprent, J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082824 · Cited by 514
Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T., Milkova, L., Korporal, M., Fritz, B., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526065 · Cited by 449
Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice
Sun, D., Whitaker, J. N., Huang, Z., Liu, D., Coleclough, C., Wekerle, H., & Raine, C. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7579 · Cited by 444
Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 440
Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis
Secor, V. H., Secor, W. E., Gutekunst, C.-A., & Brown, M. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.813 · Cited by 430
Experimental Autoimmune Encephalomyelitis in the Mouse
Miller, S. D., & Karpus, W. J. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im1501s77 · Cited by 401
Obesity predisposes to Th17 bias
Winer, S., Paltser, G., Chan, Y., Tsui, H., Engleman, E., Winer, D., & Dosch, H. ‐. (2009) · European Journal of Immunology · doi:10.1002/eji.200838893 · Cited by 377
Animal models of Multiple Sclerosis
Procaccini, C., De Rosa, V., Pucino, V., Formisano, L., & Matarese, G. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.042 · Cited by 366
Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells
Zhang, B.-N., Yamamura, T., Kondo, T., Fujiwara, M., & Tabira, T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1677 · Cited by 364
Sanna, V., Giacomo, A. D., Cava, A. L., Lechler, R. I., Fontana, S., Zappacosta, S., & Matarese, G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16721 · Cited by 362
Requirement for Leptin in the Induction and Progression of Autoimmune Encephalomyelitis
Matarese, G., Di Giacomo, A., Sanna, V., Lord, G. M., Howard, J. K., Di Tuoro, A., Bloom, S. R., Lechler, R. I., Zappacosta, S., & Fontana, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5909 · Cited by 355
Bettelli, E., Baeten, D., Jäger, A., Sobel, R. A., & Kuchroo, V. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28334 · Cited by 336
Feyerabend, T. B., Weiser, A., Tietz, A., Stassen, M., Harris, N., Kopf, M., Radermacher, P., Möller, P., Benoist, C., Mathis, D., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.015 · Cited by 335
Mei, F., Lehmann-Horn, K., Shen, Y.-A. A., Rankin, K. A., Stebbins, K. J., Lorrain, D. S., Pekarek, K., A Sagan, S., Xiao, L., Teuscher, C., et al. (2016) · eLife · doi:10.7554/elife.18246 · Cited by 321
Weber, M. S., Prod'homme, T., Patarroyo, J. C., Molnarfi, N., Karnezis, T., Lehmann‐Horn, K., Danilenko, D. M., Eastham‐Anderson, J., Slavin, A. J., Linington, C., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22081 · Cited by 318
Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A., & Linington, C. (2001) · Glia · doi:10.1002/glia.1111 · Cited by 280
“We have recently compared the pathogenic potential of MOGIgd, MOG92–106 and PLP130–151 in SJL/J mice.”
BackgroundInfluentialAharoni, R., Teitelbaum, D., Sela, M., & Arnon, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10821 · Cited by 274
Graesser, D., Solowiej, A., Bruckner, M., Osterweil, E., Juedes, A., Davis, S., Ruddle, N. H., Engelhardt, B., & Madri, J. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213595 · Cited by 273
Kigerl, K. A., McGaughy, V. M., & Popovich, P. G. (2006) · Journal of Comparative Neurology · doi:10.1002/cne.20827 · Cited by 270
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis
Bernard, C. C. A., Johns, T. G., Slavin, A., Ichikawa, M., Ewing, C., Liu, J., & Bettadapura, J. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050092 · Cited by 270
Kollias, G., Douni, E., Kassiotis, G., & Kontoyiannis, D. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01315.x · Cited by 263
Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization
Sewell, D. (2003) · International Immunology · doi:10.1093/intimm/dxg012 · Cited by 254
Ito, A., Bebo, B. F., Matejuk, A., Zamora, A., Silverman, M., Fyfe-Johnson, A., & Offner, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.542 · Cited by 254
Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS)
Glatigny, S., & Bettelli, E. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028977 · Cited by 247
Bittner, S., Afzali, A. M., Wiendl, H., & Meuth, S. G. (2014) · Journal of Visualized Experiments · doi:10.3791/51275 · Cited by 171
Berard, J. L., Wolak, K., Fournier, S., & David, S. (2010) · Glia · doi:10.1002/glia.20935 · Cited by 147
“This is best evidenced by the observation that a given mouse strain may be differentially susceptible to EAE development depending on the myelin protein used for disease induction (Mendel et al., 1995; Tuohy et al., 1988).”
BackgroundPohl, H. B. F., Porcheri, C., Mueggler, T., Bachmann, L. C., Martino, G., Riethmacher, D., Franklin, R. J. M., Rudin, M., & Suter, U. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5035-10.2011 · Cited by 145
Animal models of multiple sclerosis: From rodents to zebrafish
Burrows, D. J., McGown, A., Jain, S. A., De Felice, M., Ramesh, T. M., Sharrack, B., & Majid, A. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458518805246 · Cited by 135
Wolf, Y., Shemer, A., Levy‐Efrati, L., Gross, M., Kim, J., Engel, A., David, E., Chappell‐Maor, L., Grozovski, J., Rotkopf, R., et al. (2018) · European Journal of Immunology · doi:10.1002/eji.201847540 · Cited by 129
Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology
Kukanja, P., Langseth, C. M., Rubio Rodríguez-Kirby, L. A., Agirre, E., Zheng, C., Raman, A., Yokota, C., Avenel, C., Tiklová, K., Guerreiro-Cacais, A. O., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.030 · Cited by 124
Reducing post-traumatic anxiety by immunization
Lewitus, G. M., Cohen, H., & Schwartz, M. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.05.002 · Cited by 123
KUERTEN, S., KOSTOVABALES, D., FRENZEL, L., TIGNO, J., TARYLEHMANN, M., ANGELOV, D., & LEHMANN, P. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.06.016 · Cited by 107
Bruce, K. D., Gorkhali, S., Given, K., Coates, A. M., Boyle, K. E., Macklin, W. B., & Eckel, R. H. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00057 · Cited by 94
MBP-PLP fusion protein-induced EAE in C57BL/6 mice
Kuerten, S., Lichtenegger, F. S., Faas, S., Angelov, D. N., Tary-Lehmann, M., & Lehmann, P. V. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.021 · Cited by 54
Microglia suppress the secondary progression of autoimmune encephalomyelitis
Tanabe, S., Saitoh, S., Miyajima, H., Itokazu, T., & Yamashita, T. (2019) · Glia · doi:10.1002/glia.23640 · Cited by 52
Characterization of brain lesions in a mouse model of progressive multiple sclerosis
Levy, H., Assaf, Y., & Frenkel, D. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.017 · Cited by 50
“Another model is the C57BL/6 model,which demonstrates amonophasic peak followed by a reduction in clinical score (Gold et al., 2006;Mendel et al., 1995).”
Namekata, K., Guo, X., Kimura, A., Arai, N., Harada, C., & Harada, T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007645 · Cited by 40
Kuerten, S., & Angelov, D. N. (2008) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2007.11.001 · Cited by 40
Models for Studying Myelination, Demyelination and Remyelination
Osorio-Querejeta, I., Sáenz-Cuesta, M., Muñoz-Culla, M., & Otaegui, D. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8442-1 · Cited by 38
Experimental autoimmune encephalomyelitis (EAE) IN C57Bl/6 mice is not associated with astrogliosis
Pham, H., Doerrbecker, J., Ramp, A. A., D'Souza, C. S., Gorasia, D. G., Purcell, A. W., Ayers, M. M., & Orian, J. M. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.006 · Cited by 27
T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity
Sagan, S. A., Moinfar, Z., Moseley, C. E., Dandekar, R., Spencer, C. M., Verkman, A. S., Ottersen, O. P., Sobel, R. A., Sidney, J., Sette, A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2306572120 · Cited by 25
Huntemann, N., Vogelsang, A., Groeneweg, L., Willison, A., Herrmann, A. M., Meuth, S. G., & Eichler, S. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2021.109443 · Cited by 23
“…and female C57/BL6 mice, however, there is considerable evidence that the influence of the animals’ gender on the progression of EAE is limited further supporting our observations (Papenfuss et al., 2004; Rahn et al., 2014; Butterfield et al., 1999; Palaszynski et al., 2004; Okuda et al., 2002).”
ResultRoles of the DOCK-D family proteins in a mouse model of neuroinflammation
Namekata, K., Guo, X., Kimura, A., Azuchi, Y., Kitamura, Y., Harada, C., & Harada, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010438 · Cited by 23
“EAE was induced with the MOG35–55 peptide (MEVGWYRSPFSRVVHLYRNGK) at 6-8 weeks of age as previously reported (36-38).”
MethodRemyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
Omura, S., Sato, F., Martinez, N. E., Park, A.-M., Fujita, M., Kennett, N. J., Cvek, U., Minagar, A., Alexander, J. S., & Tsunoda, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00516 · Cited by 20
“For example, EAE can be induced in SJL/J mice or C57BL/6 mice, using different encephalitogens, such as PLP139−151, PLP178−192, MOG92−106, and MOG35−55 (13, 79).”
BackgroundParodi, B., Sanna, A., Cedola, A., Uccelli, A., & Kerlero de Rosbo, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655212 · Cited by 20
Metadata
- Authors
- Mendel, I., de Rosbo, N. K., & Ben‐Nun, A.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1995-07
- Volume
- 25
- Issue
- 7
- Pages
- 1951-1959
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2133621763
- Cited by
- 601
- References
- 44
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.